A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis

Objectives: To evaluate the safety and efficacy of adding ciclosporin A (CSA) to the treatment of patients with psoriatic arthritis (PsA) demonstrating an incomplete response to methotrexate (MTX) monotherapy. Methods: In a 12 month, randomised, double blind, placebo controlled trial at five centres...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Fraser, A, van Kuijk, A W R, Westhovens, R, Karim, Z, Wakefield, R, Gerards, A, Landewe, R, Steinfeld, S, Emery, P, Dijkmans, B, Veale, D
Format: Artigo
Jezik:Inglês
Izdano: 2005
Teme:
Extended Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755527/
https://ncbi.nlm.nih.gov/pubmed/15528283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.024463
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki